Family · Pharmaceutical analytical standards
Semaglutide
An analogue of GLP-1, the gut hormone that boosts insulin after meals: approved in 2017 for type 2 diabetes, in 2019 it became the first GLP-1 drug taken by mouth, and it is also used for weight management. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It is about 94% identical to human GLP-1, but a fatty acid chain binds it to albumin in the blood: it stays in circulation for about a week, so one injection a week is enough.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
